Also: FDA panelists find little reason to recommend metal-on-metal hip replacements; the FDA approves a new drug for overactive bladder; and a report links the global war on drugs to the spread of HIV in some countries.
June 29th, 2012
Mark Long Also: FDA panelists find little reason to recommend metal-on-metal hip replacements; the FDA approves a new drug for overactive bladder; and a report links the global war on drugs to the spread of HIV in some countries.
Posted in Drugs, FDA, Health Law, Hip replacement, HIV, Insurance, Medicaid, Supreme Court
Comments Off

